GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. Fundamental Analysis
GE HealthCare Technologies Inc. (GEHC) shows weak financial fundamentals with a PE ratio of 22.82, profit margin of 8.57%, and ROE of 17.11%. The company generates $19.6B in annual revenue with weak year-over-year growth of 0.61%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 45.3/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GEHC's fundamental strength across five key dimensions:
Efficiency Score
WeakGEHC struggles to generate sufficient returns from assets.
Valuation Score
ExcellentGEHC trades at attractive valuation levels.
Growth Score
ModerateGEHC shows steady but slowing expansion.
Financial Health Score
ExcellentGEHC maintains a strong and stable balance sheet.
Profitability Score
ModerateGEHC maintains healthy but balanced margins.
Key Financial Metrics
Is GEHC Expensive or Cheap?
P/E Ratio
GEHC trades at 22.82 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, GEHC's PEG of -0.95 indicates potential undervaluation.
Price to Book
The market values GE HealthCare Technologies Inc. at 3.69 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 9.16 times EBITDA. This is generally considered low.
How Well Does GEHC Make Money?
Net Profit Margin
For every $100 in sales, GE HealthCare Technologies Inc. keeps $8.57 as profit after all expenses.
Operating Margin
Core operations generate 13.27 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.11 in profit for every $100 of shareholder equity.
ROA
GE HealthCare Technologies Inc. generates $4.55 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
GE HealthCare Technologies Inc. produces operating cash flow of $1.98B, showing steady but balanced cash generation.
Free Cash Flow
GE HealthCare Technologies Inc. produces free cash flow of $1.50B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $3.30 in free cash annually.
FCF Yield
GEHC converts 3.93% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
22.82
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.95
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.69
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.95
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.96
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.17
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How GEHC Stacks Against Its Sector Peers
| Metric | GEHC Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 22.82 | 29.43 | Better (Cheaper) |
| ROE | 17.11% | 800.00% | Weak |
| Net Margin | 8.57% | -20145.00% (disorted) | Weak |
| Debt/Equity | 0.96 | 0.30 | Weak (High Leverage) |
| Current Ratio | 1.18 | 4.64 | Neutral |
| ROA | 4.55% | -17936.00% (disorted) | Weak |
GEHC outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews GE HealthCare Technologies Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
17.94%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
30.40%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-2.19%
Industry Style: Defensive, Growth, Innovation
Declining